Cardiovascular disease has emerged as the leading cause of non-communicable disease mortality in Nigeria and across sub-Saharan Africa — a devastating transformation in the disease burden that was, until relatively recently, dominated by infectious diseases.
Nigeria's 232 to 240 million people in 2026 face a cardiovascular crisis of extraordinary scale: hypertension affects an estimated 38 to 46 percent of Nigerian adults above the age of 30, one of the highest age-adjusted hypertension prevalence rates in the world.
This massive hypertension burden drives an epidemic of downstream cardiovascular events — coronary artery disease, heart failure, stroke, atrial fibrillation, valvular heart disease, and sudden cardiac death — that collectively represent the largest single cause of premature mortality in the country's adult population.
The global burden of disease study estimates that cardiovascular diseases now account for approximately 12 to 15 percent of all deaths in Nigeria, and the true proportion may be higher given the significant underreporting of cardiovascular causes of death in a country where most deaths occur outside healthcare facilities and without formal cause-of-death certification.
The scale of Nigeria's cardiovascular crisis is matched only by the inadequacy of the healthcare infrastructure available to address it. Nigeria has an estimated 400 to 550 cardiologists for 232 to 240 million people — a ratio of approximately 1 per 425,000 to 600,000, compared to the European Society of Cardiology benchmark of 1 per 50,000.
The country has fewer than 20 to 30 cardiac catheterisation laboratories operating at any given time — facilities capable of performing the coronary angiography and percutaneous coronary intervention (PCI) that constitute the gold standard treatment for acute myocardial infarction and stable coronary artery disease. Of these facilities, the overwhelming majority are concentrated in Lagos and Abuja — cities that together serve the healthcare needs of perhaps 20 to 25 percent of the country's population but host more than 70 to 80 percent of its specialist cardiac capacity.
The remainder of Nigeria — including the South East's 22 to 24 million people — is served by a specialist cardiac infrastructure that is barely functional by any international measure.
The human consequences of this infrastructure deficit are catastrophic and largely invisible in the public consciousness. An estimated 15,000 to 25,000 Nigerians per year require interventional cardiac procedures — coronary angioplasty, coronary artery bypass grafting, valve replacement and repair, structural heart disease correction — but current domestic capacity delivers an estimated 2,500 to 4,500 of these procedures annually.
The treatment gap of 10,000 to 20,000 patients per year who need cardiac intervention but cannot access it represents one of the largest preventable human tragedies in Nigerian healthcare. Most of these patients either die of their cardiac condition without receiving specialist assessment, receive substandard symptomatic management that does not address the underlying cardiac pathology, or — if they have the financial resources — travel to Lagos, Abuja, India, or the United Kingdom to receive the interventional cardiac care they need.
This overseas treatment flow is estimated to cost Nigerian patients and their families USD 150 million to USD 320 million annually — a sum that flows to foreign healthcare economies rather than building Nigerian cardiac infrastructure.
South Eastern Nigeria — with its 22 to 24 million people, combined GDP of USD 35 to 45 billion, active diaspora community, and high prevalence of the cardiovascular risk factors (hypertension, diabetes, obesity, metabolic syndrome) that drive cardiac disease demand — has no private dedicated cardiology hospital providing the full range of cardiac services from non-invasive diagnostics through to cardiac surgery. This is not a market gap — it is a life-threatening public health emergency that simultaneously represents one of the most compelling private healthcare investment opportunities in sub-Saharan Africa.
The investor who establishes a quality dedicated cardiology hospital in South Eastern Nigeria in 2026 is not speculating on future demand; they are addressing an existing, documented, and rapidly growing clinical and commercial need that no other institution is currently meeting.
Chapter One: Introduction and Investment Overview
Chapter Two: Business Description and Operational Model
Chapter Three: Healthcare Industry Overview
Chapter Four: Market Analysis — South Eastern Nigeria
Chapter Five: Competitive Landscape and Positioning
Chapter Six: Business Model and Revenue Streams
Chapter Seven: Financial Analysis and Investment Requirements
Chapter Eight: Risk Analysis, Implementation Plan and Conclusion
